Download The Findit App

Share Your Posts On These Major Social Networks

Instatag Your Posts to Instagram Facebook + Twitter

Right Now

Surgery Hemostat Powder Market Size Reveals the Best Marketing Channels In Global Industry

Market Overview and Report Coverage

Surgery Hemostat Powder is a type of medical powder used in surgical procedures to help control bleeding and promote clotting. It is applied directly to the surgical site to quickly stop bleeding and prevent excessive blood loss.

The future outlook of the Surgery Hemostat Powder Market looks promising, with a projected growth rate of % during the forecasted period. The market for hemostat powders is expected to expand due to the increasing prevalence of chronic diseases requiring surgical interventions and the rising demand for minimally invasive procedures. Additionally, advancements in technology leading to the development of more effective and user-friendly hemostatic powders are also contributing to market growth.

The current market trends show a shift towards the use of biodegradable and biocompatible hemostat powders, as well as an increasing focus on the development of hemostatic powders with antimicrobial properties. These trends are driven by the growing awareness of patient safety and the need for products that reduce the risk of infections and complications post-surgery.

Overall, the Surgery Hemostat Powder Market is set to witness substantial growth in the coming years, propelled by technological advancements, increasing surgical procedures, and rising healthcare expenditure worldwide.

Get a Sample PDF of the Report:


Market Segmentation

The Surgery Hemostat Powder Market Analysis by types is segmented into:

  • Microfibrillar Collagen
  • Chitosan
  • Other


Surgery Hemostat Powder market types include Microfibrillar Collagen, Chitosan, and other varieties. Microfibrillar Collagen hemostats are made from purified bovine collagen, promoting platelet aggregation and clot formation. Chitosan hemostats are derived from chitin, providing a positively charged surface to attract negatively charged red blood cells and promote clotting. The other market includes various hemostats made from different materials like gelatin, cellulose, or synthetic polymers, offering alternative solutions for achieving hemostasis during surgery.

Get a Sample PDF of the Report:


The Surgery Hemostat Powder Market Industry Research by Application is segmented into:

  • Surgical Wound Care
  • General Wound Care


Surgery Hemostat Powder is widely used in Surgical Wound Care and General Wound Care markets for its ability to quickly stop bleeding during procedures or in the management of wounds. In Surgical Wound Care, it is applied directly to surgical sites to control bleeding and promote healing. In General Wound Care, it is used to manage bleeding in various types of wounds, including cuts, abrasions, and lacerations. The hemostatic powder effectively stops bleeding, allowing for better wound management and improved patient outcomes.

Purchase this Report:


In terms of Region, the Surgery Hemostat Powder Market Players available by Region are:

North America:

  • United States

  • Canada


  • Germany

  • France

  • U.K.

  • Italy

  • Russia


  • China

  • Japan

  • South Korea

  • India

  • Australia

  • China Taiwan

  • Indonesia

  • Thailand

  • Malaysia

Latin America:

  • Mexico

  • Brazil

  • Argentina Korea

  • Colombia

Middle East & Africa:

  • Turkey

  • Saudi

  • Arabia

  • UAE

  • Korea

What are the Emerging Trends in the Global Surgery Hemostat Powder market?

The global surgery hemostat powder market is experiencing an increased demand due to the rising number of surgical procedures worldwide. Emerging trends include the development of advanced hemostatic powders with improved efficiency and reduced side effects. Current trends involve the growing adoption of hemostat powders in minimally invasive surgeries and the rising prevalence of chronic conditions leading to a higher demand for surgical interventions. Additionally, the increasing focus on healthcare infrastructure development in emerging economies is expected to drive market growth. Overall, the market is projected to witness steady growth in the coming years.

Inquire or Share Your Questions If Any Before Purchasing This Report-


Major Market Players

Bard, Pfizer, and Ethicon are among the key players in the Surgery Hemostat Powder Market. Bard, a subsidiary of Becton Dickinson, offers hemostatic powders such as Arista AH and Arista Gelfoam, which are used for controlling bleeding in surgery. Pfizer, a global pharmaceutical company, also provides hemostatic agents such as Surgicel Powder Absorbable Hemostat. Ethicon, a subsidiary of Johnson & Johnson, offers products like Surgifoam Powder Absorbable Hemostat for hemostasis.

Gelita Medical, a leading manufacturer of medical gelatin products, provides GelitaSpon hemostatic sponge for effective bleeding control in surgical procedures. Biocer, another prominent player, offers TC-Cel hemostatic powder for surgical hemostasis. These companies have been focusing on developing innovative products to cater to the growing demand for hemostatic powders in the medical industry.

The Surgery Hemostat Powder Market is witnessing substantial growth due to the increasing prevalence of surgical procedures across the globe. The market is also driven by the rising demand for advanced and effective hemostatic agents that can control bleeding quickly and efficiently during surgeries. The market size is expected to expand further as more healthcare providers adopt these hemostatic powder products for better patient outcomes.

In terms of sales revenue, companies like Bard, Pfizer, and Ethicon have reported significant earnings from their surgery hemostat powder products. These companies continue to dominate the market with their high-quality products and strong distribution networks. Overall, the Surgery Hemostat Powder Market is poised for continued growth and innovation as companies compete to meet the evolving needs of healthcare professionals and patients.

Purchase this Report:

Check more reports on

More Posts

27 Jun 2024
Load More wait